Week in review: Breast screening guideline confusion | ABUS useful as DBT adjunct | Long COVID and brain fog

Dear AuntMinnie Member, 

Despite efforts by professional medical organizations to communicate clearly with women about breast cancer screening, many remain confused about screening guidelines, according to our top story this week, posted in our Women's Imaging content area.

Researchers from the Ohio State University Comprehensive Cancer Center found that a third of respondents to a survey regarding breast cancer screening reported being unclear about when to start screening and how often.

Our second most-clicked article of the week, also posted in Women's Imaging, made the case for the use of automated breast ultrasound (ABUS) as an adjunct to digital breast tomosynthesis (DBT) in opportunistic breast cancer screening and diagnostic breast imaging.

Our third most-read story appeared in our Molecular Imaging content area: A group of French researchers provided a hypothesis for what causes long COVID brain fog, as well as a potential treatment. Also in Molecular Imaging, we highlighted a study that described a new imaging technique developed by a team from Mass General Brigham in Somerville, MA, for distinguishing tumors from normal tissue, and another that suggests that children are getting lower PET radiotracer doses than they did 20 years ago.

Finally, this week we posted a column in our Practice Management content area by contributing author Sandy Coffta of Healthcare Administrative Partners on how changes in the Medicaid program could impact radiology, and a story in our Artificial Intelligence content area that explores the question of whether ChatGPT is "too 'smart' for its own good."  

Page 1 of 3568
Next Page